[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
May 11, 1984

The Immune Response to Aerosolized Measles Vaccine

Author Affiliations

Centers for Disease Control Atlanta

JAMA. 1984;251(18):2408. doi:10.1001/jama.1984.03340420074030
Abstract

Although dramatic progress has been made in the United States in controlling measles, incidence rates elsewhere in the world remain high. In developing countries nearly 1 million children die of measles each year, with the highest rates of disease and death occurring among infants in the first year of life. Successful control of measles in this age group is impeded principally by the short interval available for successful vaccination early in life—from the time maternally derived antibodies wane to the time exposure to natural measles occurs.

The recent clinical trials of live, aerosolized measles virus vaccines1-3 have demonstrated that this alternate route of administration may prove to be particularly useful in developing countries because seroconversion can be induced in the presence of maternal antibodies. Infants were immunized successfully at an earlier age—as early as 4 months—than is possible by the parenteral route, allowing a longer interval for vaccination before exposure

References
1.
Sabin AB:  Immunization against measles by aerosol .  Rev Infect Dis 1983;5:514-523.Crossref
2.
Sabin AB, Fernández de Castro J, Flores Arechiga A, et al:  Clinical trial of inhaled aerosol of human diploid and chick embryo measles vaccine .  Lancet 1982;2:604.Crossref
3.
Sabin AB, Flores Arechiga A, Fernández de Castro J, et al:  Successful immunization of children with and without maternal antibody by aerosolized measles vaccine: I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines .  JAMA 1983;249:2651-2662.Crossref
4.
Amler RW, Orenstein WA, Bart KJ:  Aerosolized measles vaccine—will it open the window?  Rev Infect Dis 1983;5:524-526.Crossref
5.
Morley DC:  Measles vaccines by aerosol: Eradication this century?  Trop Doct 1983;13:90.
6.
Sabin AB, Flores Arechiga A, Fernández de Castro J, et al:  Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine: II. Vaccine comparisons and evidence for multiple antibody response .  JAMA 1984;251:2363-2371.Crossref
7.
Krugman S, Giles JP, Friedman H, et al:  Studies on immunity to measles . J Pediatr 1965;66:471-488.Crossref
8.
Albrecht P, Herrmann KL, Burns GR:  Role of virus strain in conventional and enhanced measles plaque neutralization test .  J Virol Methods 1981;3:251-260.Crossref
9.
Voller A, Bidwell D, Bartlett A:  Microplate enzyme immunoassays for the immunodiagnosis of viral infections , in Rose NR, Friedman H (eds):  Manual of Clinical Immunology. Washington, DC, American Society for Microbiology, 1976, pp 506-512.
×